Australia, Dec. 25 -- Theranostik Pharma Gmbh, owns the trademark (2581444) for 'IODAX' till May 23, 2035.
Status: protected:
Registered/protected
Classes: 5 [Radiopharmaceutical products; diagnostic radiopharmaceutical preparations; radioactive pharmaceutical preparations for in vivo diagnostics; radioactive pharmaceutical preparations for therapeutic use; radioactive substances for medical purposes; radioactive elements for medical use; sealed radioactive substances for medical use; radio-isotope markers for therapeutic or diagnostic use; radioactive preparations for veterinary diagnosis; radiological contrast substances for medical purposes; contrasting agents for diagnostic ultrasound imaging; diagnostic reagents and contrast media for medical use; diagnostic agents for pharmaceutical use; none of the aforesaid being in relation to medicines containing iron, oral iron compositions for the treatment of iron deficiency and/or anaemia.], 10 [Radioisotope therapy apparatus and instruments; radiation oncology apparatus for medical use; radio cardiographic apparatus for medical purposes; apparatus for radionuclide imaging.] and 42 [Research in the field of interventional radiology; research relating to radiopharmaceuticals, radiotherapeutics and radiodiagnostics; development of radiopharmaceutical preparations and medications and radiodiagnostics and radiotherapeutics.]
Type of Mark: Word
Date of Acceptance: Oct. 17
Registration Advertised: Dec. 24
For further details contact JMSD IP Pty. Ltd. and Vossius & Partner Patentanwalte Rechtsanwalte mbB.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2581444.
Disclaimer: Curated by HT Syndication.
